Ethical innovation: The tech and biotech industries must focus on developing technologies and business models that respect individual privacy while advancing scientific knowledge.
Public discourse: A broader societal conversation about the value, risks, and ethical implications of genetic data collection and analysis is crucial.
As we stand at this crossroads, the decisions made by 23andMe, regulators, and consumers will have far-reaching implications. They will shape not only the future of personal genomics but also set precedents for how we handle sensitive personal data in an increasingly data-driven world.